# Tetanus: Physiology, Symptoms, Treatment, and Prevention
> Discover the science of Tetanus (Clostridium tetani). Learn about the neurotoxin tetanospasmin, clinical symptoms like lockjaw, and modern treatment protocols.

Tags: tetanus, clostridium-tetani, physiology, medical-education, vaccination, immunology, lockjaw, neurology
## Slide 1: TETANUS | The Silent Spasm
- A physiological perspective on the neurological disease.
- Date: March 2026.

## Slide 2: What is Tetanus? Background & Diagnosis
- **Definition**: Fatal neurological disease caused by tetanospasmin from *Clostridium tetani*.
- **Mechanism**: Blocks inhibitory neurotransmitters (GABA & glycine), leading to uncontrolled excitatory firing.
- **Diagnosis**: Clinical signs including trismus (lockjaw), risus sardonicus, and opisthotonus.

## Slide 3: Systems Affected & The Science Behind Tetanus
- **Primary**: Nervous system (loss of inhibitory control).
- **Secondary**: Musculoskeletal (rigidity, bone fractures).
- **Tertiary**: Autonomic control (hypertension, tachycardia).
- **Pathway**: Toxin enters via wound -> Retrograde transport to spinal cord -> Blocks GABA/Glycine.

## Slide 4: Causes & Infection Pathway
- Common entry: Puncture wounds, lacerations, burns, and neonatal umbilical stumps.
- Minimal lethal dose: 2.5 nanograms per kg of body weight.

## Slide 5: Signs & Symptoms
- **Generalized Tetanus**: >80% of cases; first symptom is usually trismus.
- **Neonatal Tetanus**: High mortality, often due to contaminated umbilical stumps.
- **Behavioral**: Extreme anxiety and intense pain; patients remain fully conscious.

## Slide 6: Epidemiology & Demographics
- **Global**: ~1 million cases/year; mortality 213k–293k.
- **US Trends**: ~27–37 cases/year; >95% decline since 1947.
- **Risk Groups**: Elderly with waning immunity, injection drug users, and diabetics.

## Slide 7: Treatment Approaches
- **Wound Care**: Debridement of necrotic tissue.
- **Neutralizing Toxin**: Human Tetanus Immune Globulin (TIG).
- **Antibiotics**: Metronidazole or Penicillin G.
- **Spasm Control**: Benzodiazepines and Magnesium sulfate.
- **Supportive**: ICU care, mechanical ventilation, and dark/quiet environment.

## Slide 8: Prognosis
- **With Modern Care**: 10–20% global fatality rate.
- **Without Treatment**: 70–90% mortality (approaching 100% in neonatal cases).
- **PHILLIPSON SCORE**: Grades from I (Mild) to IV (Very Severe).

## Slide 9: Prevention & Vaccines
- **Vaccines**: DTaP (children), Td (booster), Tdap.
- **Prophylaxis**: TIG + Td vaccine for high-risk wounds in unvaccinated individuals.
- **Efficacy**: Nearly 100% preventable with a full series.

## Slide 10: Notable History & Research
- **Historical figures**: John A. Roebling and Fred Thomson died of tetanus.
- **Milestones**: 1884 (First description), 1890 (Antitoxin development), 1924 (Toxoid vaccine developed).
- **Key Organizations**: WHO, CDC, PATH, GAVI.
---
This presentation was created with [Bobr AI](https://bobr.ai) — an AI presentation generator.